BioLife Solutions (BLFS)
(Delayed Data from NSDQ)
$25.57 USD
-0.71 (-2.70%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $25.57 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth D Momentum D VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
BLFS 25.57 -0.71(-2.70%)
Will BLFS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BLFS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BLFS
Are Medical Stocks Lagging Bayer (BAYRY) This Year?
Does BioLife Solutions (BLFS) Have the Potential to Rally 25.6% as Wall Street Analysts Expect?
BLFS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks Industry Outlook Highlights Envista, BioLife Solutions, InfuSystems and MariMed
4 Medical Product Stocks to Watch From a Challenging Industry
BioLife Solutions (BLFS) Upgraded to Strong Buy: Here's Why
Other News for BLFS
Is BLFS set to rally? Crossed Above 20 Day Moving Average shows up after gaining 2.72%
Fell Below 20 Day Moving Average appears for BLFS after 1.52% move
Is BLFS set to rally? 20 Day Moving Average Support shows up after climbing 0.7%
Insider Sell: Sarah Aebersold Sells Shares of BioLife Solutions Inc (BLFS)
20 Day Moving Average Support appears for BLFS after 1.14% move